Previous 10 | Next 10 |
home / stock / hls:cc / hls:cc news
New REDUCE-IT® Analyses Show Vascepa® (Icosapent Ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline Canada NewsWire Analysis Also Found ...
HLS Therapeutics Announces Q3 Fiscal 2023 Financial Results and Renewal of Normal Course Issuer Bid Canada NewsWire TORONTO , Nov. 9, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet...
K-Bro Linen Inc. (KBL:CA) is expected to report $0.57 for Q3 2023 Yellow Pages Limited (Y:CA) is expected to report for Q3 2023 Ascot Resources Ltd. (AOT:CA) is expected to report for Q3 2023 Park Lawn Corporation (PLC:CA) is expected to report $0.27 for Q3 2023 Hut 8 Mining Corp....
HLS Therapeutics Inc. (HLS:CA) is expected to report $-0.16 for Q3 2023
HLS Therapeutics to Host Q3 Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO , Oct. 26, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q3 Fiscal 2023 financial results on Thur...
HLS Therapeutics to Present at H.C. Wainwright's 25th Annual Global Investment Conference Canada NewsWire TORONTO , Sept. 6, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS"...
HLS Therapeutics Announces Q2 Fiscal 2023 Financial Results Canada NewsWire TORONTO , Aug. 10, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS") and cardiovascular mark...
HLS Therapeutics to Host Q2 Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO , Aug. 3, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q2 Fiscal 2023 financial results on Thursday, ...
HLS Therapeutics Announces Updates to its Board of Directors Canada NewsWire John Welborn, Jr. is appointed Chair of the Board, succeeding Greg Gubitz , who is retiring John Hanna is appointed to the HLS Board as an independent director ...
HLS Therapeutics Announces Agreement with Polar Asset Management Partners and Retirement of Two Directors from the Board of Directors Canada NewsWire HLS Directors J. Spencer Lanthier and Don DeGolyer will not be standing for re-election at the 2023 AGM ...
News, Short Squeeze, Breakout and More Instantly...
HLS Therapeutics Inc. Company Name:
HLS:CC Stock Symbol:
TSXC Market:
Gold Springs Resource Corp. (GRC:CA) is expected to report for Q1 2024 Primo Water Corporation (PRMW:CA) is expected to report $0.18 for Q1 2024 Greenlane Renewables Inc. (GRN:CA) is expected to report $-0.01 for Q1 2024 Kelso Technologies Inc. (KLS:CA) is expected to report for Q1 20...
HLS Therapeutics Announces Q1 2024 Financial Results Canada NewsWire TORONTO , May 9, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders...
HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call Canada NewsWire TORONTO , April 25, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q1 fiscal 2024 financial results on Thursday...